The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs

The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs

Eosinophilic esophagitis (EoE) is a multifaceted disease characterized by a wide heterogeneity of clinical manifestations, endoscopic and histopathologic patterns, and responsiveness to therapy. From the perspective of an effective approach to the patient, the different inflammatory mechanisms invol...

Full description

Bibliographic Details
Main Authors: Erminia Ridolo, Alessandro Barone, Martina Ottoni, Silvia Peveri, Marcello Montagni, Francesca Nicoletta
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
biological drugs
benralizumab
cendakimab
dupilumab
eosinophilic esophagitis
lirentelimab mepolizumab
Online Access:https://www.mdpi.com/1422-0067/25/3/1702

Internet

https://www.mdpi.com/1422-0067/25/3/1702

Similar Items